EFFICACY AND SAFETY OF THE ANTITUMOR RVP PROGRAM (LENALIDOMIDE, BORTEZOMIB, PREDNISONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: PB2150
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI